Latest News
AngioDynamics, Inc.
- AngioDynamics study shows survival benefit for pancreatic cancer By Investing.com
- Canaccord reiterates AngioDynamics stock rating on growth platforms
- AngioDynamics names new CEO
- AngioDynamics Names Eric Honroth CEO as Jim Clemmer Retires After 10 Years
- AngioDynamics Q1FY27 Results: Adjusted EPS beats estimate, sales rise 6.9%
- AngioDynamics Q1 Earnings Call Highlights
- Earnings call transcript: AngioDynamics beats Q1 2026 forecasts as shares fall premarket
- AngioDynamics Q1 Revenue Rises 6.9% as Med Tech Growth Leads; FY2027 Outlook Reiterated
- Why is AngioDynamics stock sliding today?
- AngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
- AngioDynamics Q1 FY 2027 slides: Med Tech growth accelerates to 13%
- Why AngioDynamics Crashed Today
Headlines from the last 30 days, linking to the original publishers. See all market news →